$786 Million is the total value of Iron Triangle Partners LP's 27 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EHC | Buy | ENCOMPASS HEALTH CORP | $63,473,000 | +53.5% | 775,000 | +55.0% | 8.07% | +50.6% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $59,531,000 | +28.2% | 160,000 | +20.8% | 7.57% | +25.7% |
| MOH | Buy | MOLINA HEALTHCARE INC | $46,752,000 | +46.5% | 200,000 | +33.3% | 5.94% | +43.7% |
| LH | New | LABORATORY CORP AMER HLDGS | $43,355,000 | – | 170,000 | +100.0% | 5.51% | – |
| ALGN | New | ALIGN TECHNOLOGY INC | $37,907,000 | – | 70,000 | +100.0% | 4.82% | – |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $37,128,000 | +22.2% | 910,000 | +1.0% | 4.72% | +19.9% |
| HAE | Buy | HAEMONETICS CORP MASS | $36,633,000 | +12.0% | 330,000 | +19.8% | 4.66% | +9.9% |
| ABBV | New | ABBVIE INC | $32,466,000 | – | 300,000 | +100.0% | 4.13% | – |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $31,172,000 | +50.2% | 935,805 | +17.0% | 3.96% | +47.3% |
| LUNG | New | PULMONX CORP | $27,444,000 | – | 600,000 | +100.0% | 3.49% | – |
| CNMD | Buy | CONMED CORP | $26,118,000 | +57.2% | 200,000 | +34.8% | 3.32% | +54.2% |
| NVRO | Buy | NEVRO CORP | $25,110,000 | -14.0% | 180,000 | +6.7% | 3.19% | -15.7% |
| OSH | New | OAK STR HEALTH INC | $18,995,000 | – | 350,000 | +100.0% | 2.42% | – |
| IDXX | New | IDEXX LABS INC | $17,126,000 | – | 35,000 | +100.0% | 2.18% | – |
| New | DERMTECH INC | $12,698,000 | – | 250,000 | +100.0% | 1.62% | – | |
| OHPAU | New | ORION ACQUISITION CORPunit 02/19/2026 | $10,989,000 | – | 1,100,000 | +100.0% | 1.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.